文献速递主动脉疾病

医师改良支架移植物治疗钝性胸主动脉损伤:获益是否值得?

Physician-Modified Stent Graft for Blunt Thoracic Aortic Injuries: Do the Benefits Worth the Trouble?
PubMed 文献 · Ann Vasc Surg · 2022-10-18

研究回顾性分析前瞻性注册数据,纳入2008年10月至2020年10月因钝性胸主动脉损伤行TEVAR的58例患者,其中10例(17.2%)因需覆盖左锁骨下动脉而使用医师改良支架移植物。医师改良支架移植物技术成功率为90.0%,无卒中、截瘫或逆行夹层,左锁骨下动脉一期通畅率1年时为90%,而左锁骨下动脉覆盖组为28.8%(P<0.01)。作者认为医师改良支架移植物在处理近端锚定区短的钝性胸主动脉损伤中可行且有效,但长期结局和耐久性有待进一步评估。

要点

  • 58例TEVAR中23例(39.6%)需2区锚定,其中10例(17.2%)使用医师改良支架移植物。
  • 医师改良支架移植物技术成功率90.0%,开窗支架为100%,无卒中、截瘫或逆行夹层。
  • 医师改良支架组左锁骨下动脉1年一期通畅率90%,左锁骨下动脉覆盖组为28.8%(P<0.01)。

核心结论

  • 医师改良支架移植物用于近端锚定区短的钝性胸主动脉损伤是可行且有效的。
  • 长期结局和耐久性有待进一步评估。

研究设计与样本

  • 回顾性分析前瞻性注册数据,纳入2008年10月至2020年10月因钝性胸主动脉损伤行胸主动脉腔内修复术的全部患者。
  • 自2015年起,需要覆盖左锁骨下动脉的患者接受医师改良近端扇形或单开窗支架移植物治疗。
  • 术后早期行计算机断层扫描,随访在3个月、6个月和每年进行。

主要发现

  • 58例因钝性胸主动脉损伤行胸主动脉腔内修复术的患者中,23例(39.6%)需要2区锚定,其中10例(17.2%)接受医师改良支架移植物治疗。
  • 医师改良支架移植物组中位年龄48[31-64.5]岁,78.2%(n=18)为男性,中位损伤严重度评分为38[27-55.5]。
  • 全部人群中25.8%(n=15)行左锁骨下动脉覆盖,其中5例行左锁骨下动脉转位。
  • 医师改良支架移植物中位修改时间为18[14-27]分钟,总体技术成功率为90.0%,开窗支架移植物为100%。
  • 未观察到卒中、截瘫或逆行夹层;医师改良支架移植物组左锁骨下动脉1年一期通畅率为90%,左锁骨下动脉覆盖组为28.8%(P<0.01)。

临床怎么用

  • 对于钝性胸主动脉损伤需覆盖左锁骨下动脉且近端锚定区短的患者,医师改良支架移植物是可行且有效的处理方式。
  • 作者认为长期结局和耐久性有待进一步评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obtaining a suitable proximal landing zone in blunt thoracic aortic injuries (BTAI) often necessitates coverage of the left subclavian artery (LSA). This study aimed to evaluate the outcomes of physician-modified endovascular grafts (PMEGs) in this indication. METHODS: We performed a retrospective analysis of a prospective registry including all patients who had undergone a thoracic endovascular aortic repair (TEVAR) for BTAI from October 2008 to October 2020. Starting in 2015, patients requiring coverage of the LSA were either treated using a physician-modified proximal scalloped or single-fenestrated stent graft. After an early postoperative computed tomography scan, follow-up was performed at 3 months, 6-months, and yearly. RESULTS: Among 58 patients treated with TEVAR for BTAI, 23 (39.6%) patients required a zone 2 landing zone of which 10 (17.2%) patients were treated with PMEGs. The median age was 48 [31-64.5] years, and 78.2% (n = 18) patients were male. The median Injury Severity Score was 38 [27-55.5]. Coverage of the LSA was performed in 25.8% (n = 15) of the total population in which 5 patients had an LSA transposition. The median modification time was 18 [14-27] minutes. Technical success of PMEGs was 90.0% overall and 100% for fenestrated stent grafts. No stroke, paraplegia, or retrograde dissection was observed. The primary patency of the LSA in the PMEGs group was 90 % at 1 year and 28.8 % in the LSA coverage group (P < 0.01). CONCLUSIONS: The use of PMEGs is feasible and effective in the management of BTAI with a short proximal landing zone. Further evaluation of long-term outcomes and durability are awaited.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lounes Y, Belarbi A, Hireche K, et al. Physician-Modified Stent Graft for Blunt Thoracic Aortic Injuries: Do the Benefits Worth the Trouble? Ann Vasc Surg. 2022. PMID: 36270548. doi:10.1016/j.avsg.2022.09.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。